Understanding International Flavors & Fragrances (IFF) after recent stock moves

International Flavors & Fragrances (IFF) has drawn fresh attention after its recent share price moves, prompting investors to reassess how the company’s mix of fragrance, flavor and biosciences businesses might support the stock.

The latest 7 day share price return of 7.20% and 90 day share price return of 12.44% point to building momentum, although the 5 year total shareholder return declined 38.21%. This highlights how recent strength follows a much weaker longer run.

If this kind of turnaround story has your attention, it can be useful to widen your watchlist and check out 20 top founder-led companies

With IFF trading at US$78.27, showing an indicated 38.21% decline in 5-year total return but a reported intrinsic discount of 38.21%, the key question is whether there is a genuine opportunity here or if the market is already pricing in future growth.

Most Popular Narrative: 13.7% Undervalued

IFF's most followed narrative points to a fair value of $90.71 versus the recent $78.27 share price, framing the current move as a potential discount.

Recent divestitures of commodity businesses (e.g., Pharma Solutions, Soy Crush, Concentrates, Lecithin) and the ongoing strategic evaluation of the Food Ingredients segment are increasing IFF's focus on differentiated, higher-margin, innovation-driven products, which supports future margin expansion and higher earnings quality.

Want to see what sits behind that margin story and fair value gap? Revenue mix shifts, earnings rebuild and a rich future profit multiple all sit at the core.

Result: Fair Value of $90.71 (UNDERVALUED)

However, this fair value story still depends on fragile pieces, including pressure in fragrance ingredients from low cost competitors and ongoing weakness in parts of Health & Biosciences.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another way to look at IFF’s valuation

The first view leaned on fair value and price targets, but the current P/E of 24.2x tells a slightly different story. It sits below the US Chemicals industry at 28.1x and well below peer averages at 63.9x, yet above IFF’s own fair ratio of 20.4x.

In practical terms, that mix of “cheaper than peers, richer than its fair ratio” suggests both some cushion and some valuation risk if sentiment turns. The key question for investors is whether earnings progress is strong enough to keep the stock closer to peers or pull it back toward that fair ratio.

Next Steps

Interested in how this mix of pressure and potential really stacks up for you? Act quickly, review the data yourself, and weigh the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you only stop at IFF, you might miss other stocks that better match your style, so take a few minutes to scan these hand picked ideas.

• Target quality at a discount by checking out 44 high quality undervalued stocks with solid fundamentals already built into the screen.
• Strengthen your income stream by reviewing 8 dividend fortresses that combine higher yields with a focus on consistency.
• Sleep easier at night by focusing on 70 resilient stocks with low risk scores where resilience and stability are front and center.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.